Jay P. McLaughlin
Affiliations: | Psychology | Northeastern University, Boston, MA, United States |
Area:
Experimental Psychology, Psychobiology PsychologyGoogle:
"Jay McLaughlin"Mean distance: 35622
Parents
Sign in to add mentor| Jean M. Bidlack | grad student | 1993-1998 | Rochester (Chemistry Tree) |
| Charles Chavkin | post-doc | 1999-2004 | University of Washington |
Children
Sign in to add trainee| Khampaseuth Rasakham | grad student | 2008 | Northeastern University |
| Amanda N. Carey | grad student | 2010 | Northeastern University |
| Thomas Cirino | grad student | 2015-2020 | University of Florida |
| Ariana Brice-Tutt | grad student | 2017-2021 | University of Florida |
| Lisa Wilson | grad student | 2017-2022 | University of Florida |
| Amy R. Alleyne | grad student | 2018-2023 | University of Florida |
| Jason J. Paris | post-doc | 2011-2014 | Torrey Pines Institute for Molecular Studies |
Collaborators
Sign in to add collaborator| Predrag Cudic | collaborator | 2012- | University of Florida,School of Pharmacy, Gainesville (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Che T, Varga B, Bernhard SM, et al. (2024) Structure-Guided Design of Partial Agonists at an Opioid Receptor. Research Square |
| O'Brien ES, Rangari VA, El Daibani A, et al. (2024) A µ-opioid receptor modulator that works cooperatively with naloxone. Nature |
| Li Y, Eans SO, Ganno-Sherwood M, et al. (2023) Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide. Molecules (Basel, Switzerland). 28 |
| Scherrer KH, Eans SO, Medina JM, et al. (2023) Tryptophan Substitution in CJ-15,208 ([Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference. Pharmaceuticals (Basel, Switzerland). 16 |
| Rayala R, Tiller A, Majumder SA, et al. (2023) Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration. Molecules (Basel, Switzerland). 28 |
| Zhu J, Quizon PM, Wang Y, et al. (2022) SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice. Neuropharmacology. 109239 |
| McLaughlin JP, Rayala R, Bunnell AJ, et al. (2022) Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics. International Journal of Molecular Sciences. 23 |
| Wilson LL, Alleyne AR, Eans SO, et al. (2022) Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain. Molecules (Basel, Switzerland). 27 |
| Brice-Tutt AC, Eans SO, Yakovlev D, et al. (2022) An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference. Pharmacology, Biochemistry, and Behavior. 217: 173405 |
| Zhang P, Guergues J, Alleyne AR, et al. (2022) Novel Histone Modifications in Microglia Derived from a Mouse Model of Chronic Pain. Proteomics. e2100137 |